Kenneth S. Cohen to Drug Hypersensitivity
This is a "connection" page, showing publications Kenneth S. Cohen has written about Drug Hypersensitivity.
Connection Strength
0.038
-
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217.
Score: 0.038